日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis

帕博利珠单抗、伊匹木单抗和纳武利尤单抗单药及联合治疗结直肠癌的疗效:系统评价和荟萃分析

Adrianto, Albertus Ari; Riwanto, Ignatius; Sadhana, Udadi; Paramita, Dewi Kartikawati; Setyawan, Henry; Tjandra, Kevin Christian; Respati, Danendra Rakha Putra; Rampengan, Derren David Christian Homenta; Ramadhan, Roy Novri; Jangkang, Gastin Gabriel; Mahati, Endang; Winona, Patricia

Morphological Changes and Inflammation Preceded the Pathogenesis of 1,2-Dimethylhydrazine-Induced Colorectal Cancer

1,2-二甲基肼诱发的结肠直肠癌发病机制之前的形态学变化和炎症

Albertus Ari Adrianto, Ignatius Riwanto, Udadi Sadhana, Henry Setyawan, Endang Mahati, Sitarina Widyarini, Afranetta Aulya Asri Wandita, Dewi Kartikawati Paramita

Immunohistochemical Expression of IDH1, ATRX, Ki67, GFAP, and Prognosis in Indonesian Glioma Patients

IDH1、ATRX、Ki67、GFAP的免疫组织化学表达与印尼胶质瘤患者的预后

Priambada, Dody; Thohar Arifin, Muhamad; Saputro, Abdi; Muzakka, Azka; Karlowee, Vega; Sadhana, Udadi; Bakhtiar, Yuriz; Prihastomo, Krisna Tsaniadi; Risdianto, Ajid; Brotoarianto, Happy Kurnia; Andar, Erie; Muttaqin, Zainal

Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia

在印度尼西亚,不同原料来源的重组乙肝疫苗与乙肝(Bio Farma)疫苗相比,其保护性和安全性如何?

Nency, Yetty M; Rahmadi, Farid Agung; Mulyono; Anantyo, Dimas Tri; Farhanah, Nur; Hapsari, Rebriarina; Farida, Helmia; Sadhana, Udadi; Djagat, Herry; Kristina, Tri Nur; Juniarto, Achmad Zulfa; Puspita, Mita; Sari, Rini Mulia; Bachtiar, Novilia Sjafri

Role of Cell-Origin Profiling Using Immunohistochemistry to Predict the Survival of Patients with Diffuse Large B-Cell Lymphoma in Indonesia

利用免疫组织化学进行细胞来源分析在预测印度尼西亚弥漫性大B细胞淋巴瘤患者生存率中的作用

Istiadi, Hermawan; Sadhana, Udadi; Puspasari, Dik; Miranti, Ika Pawitra; Karlowee, Vega; Listiana, Devia Eka; Prasetyo, Awal